Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court
Pharmaceutical Technology
FEBRUARY 22, 2023
The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months. The legal dispute is centered around rival cholesterol-lowering drugs produced by the two companies, which were approved in the summer of 2015. Both drugs come with a high price tag.
104 
Let's personalize your content